Skip to content
Health

The strategy the European Union currently uses for the acquirement of COVID-19 vaccines is clearly political. It is also about profits – if Sputnik V vaccinations were taking place, the Pfizer vaccine would not be used as much which would result in lower profits for the Western company. Those who question the quality of Sputnik V just because it originates in Russia are simply stupid.

Is the EU's vaccine strategy clearly political and focused on profits of Western companies?

Falseaccording to EUvsDisinfo

EUvsDisinfo checked this claim on 14 February 2021.

“disinformation”

  1. English

    Read the fact-check at EUvsDisinfo

Why it is false, according to EUvsDisinfo

  • Vaccines must first apply for a review by the European Medicines Agency before they can be approved in the European Union.
  • Sputnik V's producer, the Gamaleya Centre, only applied for an EMA rolling review in March 2021, so the review is not finished.

Summarised by Factiz from the EUvsDisinfo disproof (CC BY 4.0). Read the disproof

Report an error

Around this claim

First seen
14 February 2021, cz.sputniknews.com, according to EUvsDisinfo (EEAS East StratCom Task Force)

Where it turned up

  • Seen at cz.sputniknews.com, according to EUvsDisinfo (EEAS East StratCom Task Force), 14 February 2021

Related

NamesEuropean UnionPfizerRussia

Something wrong here? Report it by emailinfo@factiz.org

The verdict belongs to the newsroom: report an error in it to them, through their article above. Report an error in what Factiz added, such as the translation, the theme or the names, to us.

Record from: EUvsDisinfo, European External Action Service. Licence: EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0.

The sources are the verdict.